ARTV Competitors & Alternatives
Compare Artiva Biotherapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
ARTV
Main Stock$6.83
Tradestie Score
55
Market Cap
$71.32M
Revenue Growth
-1.0%
Analyst Upside
+424.2%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CAPR
Capricor Therapeutics Inc
|
$8.95
|
$357.51M | - | 49 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$15.51
|
$354.45M | - | 61 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$36.99
|
$353.70M | - | 64 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.72
|
$350.98M | - | 55 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.74
|
$341.56M | - | 37 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$4.19
|
$332.96M | - | 69 | Compare |
|
REPL
Replimune Group, Inc.
|
$13.07
|
$328.62M | - | 65 | Compare |
|
PEPG
PepGen Inc. Common Stock
|
$2.28
|
$323.75M | - | 56 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.24
|
$307.12M | - | 42 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.18
|
$304.12M | - | 54 | Compare |
More ARTV Analysis
Data updated: Oct 04, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry